Immunodepression and Immunosuppression During Aging

A for a book on immunology which primarily focuses on the needs of medical and clinical research students was recognized. This book, "Immunosuppression - Role in Health and Diseases" is relatively short and contains topics relevant to the understanding of human immune system and its role in health and diseases. Immunosuppression involves an act that reduces the activation or efficacy of the immune system. Therapeutic immunosuppression has applications in clinical medicine, ranging from prevention and treatment of organ/bone marrow transplant rejection, management of autoimmune and inflammatory disorders. It brings important developments both in the field of molecular mechanisms involved and active therapeutic approaches employed for immunosuppression in various human disease conditions. There was a need to bring this information together in a single volume, as much of the recent developments are dispersed throughout biomedical literature, largely in specialized journals. This book will serve well the practicing physicians, surgeons and biomedical scientists as it provides an insight into various approaches to immunosuppression and reviews current developments in each area.

expansions are often observed in CD8 T cells, probably as a result of chronic and repeated infections. This reduces the diversity of the repertoire (Ahmed, Lanzer et al. 2009), decreases the potential to drive an immune response and affects the CD4/CD8 ratio (LeMaoult, Messaoudi et al. 2000;Messaoudi, Lemaoult et al. 2004 ;Clambey, van Dyk et al. 2005;Goronzy and Weyand 2005;Pawelec, Akbar et al. 2005;Clambey, Kappler et al. 2007) reviewed in (Blackman and Woodland 2011). With age CD4 T cells have increased longevity (Tsukamoto, Clise-Dwyer et al. 2009) while under normal homeostatic conditions recent thymic migrant have to compete with already established mature naïve T cells (Houston, Higdon et al. 2011). On the life-scale, lymphocyte and lymphoid organ emergence, cell selection and expansion during ontogeny are critical features of the immune system construction and determine its efficiency at the adult age. Thus, during life, homeostasis is maintained with a dynamic equilibrium between diversity and efficiency (naïf vs. effector/memory lymphocytes) with two periods of physiological relative immunodeficiency, early in ontogeny and in advanced old age. In females, the gestation also represents a relative immunodepressive period leading to embryo/foetus acceptance. During the life, dynamic equilibrium ensures complex interactions of highly diversified circulating lymphocytes, with high turnover, responsible for tolerance and immune protection of the organism, while controlling most pathogens. Aging however induces complex and progressive alterations that find their origins at different biological scales: organism, organ, cell populations, cells, molecules, genes. Table  1 summarizes some of these general observations. Table 1. Aging alters immune functions at various biological levels. The levels can interfere with each other as depicted by the arrows.

www.intechopen.com
Thymic involution is a primary sign of immunological aging at puberty and the reduced production of diverse naïve T cells is compensated for in the immune system by the proliferation of existing peripheral T cells. In very old humans and mice this leads to alteration in the T cell repertoire, appearance of oligoclonal expansions, restricting the lymphocyte repertoire (Messaoudi, Lemaoult et al. 2004;Clambey, van Dyk et al. 2005). Thymic involution is likely the result of alterations at different levels, aging being related to alteration of molecular process as somatic recombination of V-D-J gene, that seems related to deficiency in the RAG enzyme, leading to diminution of thymic export (Hale, Boursalian et al. 2006), and recent thymic emigrants (Boursalian, Golob et al. 2004). Direct alterations of thymocyte proliferation, differentiation process or environmental factors as alteration of the thymic epithelium also impact thymocyte differentiation (Thoman 1995;Yehuda, Friedman et al. 1998;Andrew and Aspinall 2001). In elderly humans, altered homeostasis also participates to decrease ratio of naive/memory and CD4/CD8 cells, with senescence of CD4 T cells (Ferrando-Martinez, Ruiz-Mateos et al.). Moreover, genetic & epigenetic mechanisms (Yung and Julius 2008) participate to control or trigger aging alterations (Dorshkind, Montecino-Rodriguez et al. 2009). We need to improve our knowledge on (i) the effects of genetic variability and aging, on lymphocyte dynamics population, repertoire selection and related immunodepression and (ii) the effects of immunosuppressive treatment in aged mice. Murine models may give some indications to better understand similar perturbations in humans or the ways to study and model them. In addition to aging that induces immunodepression, various clinical treatments used to control many diseases, induce immunosuppression. These treatments are designed to control unwanted immune responses, such as inflammation, autoimmunity, graft rejection, Graft Versus Host Disease (GVHD). Other treatments designed to fight cancer have the drawback to induce immunodepression since they target dividing (tumour) cells but they also kill the dividing cells from the immune system. The drawbacks of these treatments are their relative low specificity that impacts high dynamics biological system with high cell proliferation like lymphoid and haematopoietic systems. Aiming to understand the origins of immunodepression during aging or effects upon treatments but also the capacity of the immune system to regenerate should be coupled with the study of the immune system in homeostatic conditions. This requires specific investigation design related to system biology investigation and modelling. These different levels of alteration with aging are related to the immune system complexity at inter-and intra-cell signalling, receptor diversity, clonotype selection and competition (Leitao, Freitas et al. 2009), fluid dissemination through the organism, homeostatic regulation and adaptation to a changing environment. In short, the immune system is a "complex system". In general, a complex system is comprised of a great number of heterogeneous entities, among which local interactions create multiple levels of collective structure and organization. Such systems require analysis at several spatial and temporal scales. Scientists are faced with radically new challenges when trying to observe, describe, control and develop original theories about these complex biological systems. We previously discussed concepts on the evaluation of multiscale systems dynamics, fluctuations, stability and resilience (Lavelle, Berry et al. 2008). In addition to looking to individual elements and isolated contexts, it is necessary to integrate information and devise more holistic approaches (Benoist, Germain et al. 2006;Cohn and Mata 2007). This is particularly true of the immune system (Cohen 2007). We recently delineated three www.intechopen.com challenges 1 to study the complexity of the immune systems: (i) the identification of lymphocyte populations, (ii) the reconstruction of their dynamics and repertoire selection process (iii) the mechanisms involved in the resilience or instabilities to perturbations, immune dysfunction in order to improve immuno-intervention strategies. It is obvious that the fluctuations related to aging that lead to progressive immunodepression or induced by therapeutic immunosuppression are both the consequence of the perturbations of the immune system and changes in the initial equilibrium state. Here, we moreover challenge the fact that immunosuppression during aging might increase the physiological immunodepression. A number of studies aiming at providing a global analysis and comprehensive modelling of immunological systems have flourished around the world (Rangel, Angus et al. 2004;Braga-Neto and Marques 2006;Morel, Ta'asan et al. 2006;Petrovsky and Brusic 2006;Borghans and de Boer 2007;Chan and Kepler 2007;Efroni, Harel et al. 2007;Souza-e-Silva, Savino et al. 2009). We recently reported on methods and strategies to investigate lymphocyte dynamics and repertoires as well as the modelling concepts and formalism (Thomas-Vaslin & al. in press). Moreover scientists are faced with data storage and sharing. The SIDR initiative to store data with metadata and share them is under current development as illustrated in the "T cell and aging" project 2 . Interestingly, the high turnover and division of lymphocytes was revealed by the initial use of immunosuppressive drugs. In fact the early investigation of lymphoid cell dynamics and their precursors are related to the effects of perturbation induced by immunosuppression, as irradiation (Sprent, Anderson et al. 1974;Anderson, Olson et al. 1977;McLean and Michie 1995), following chemotherapy for cancer (Mackall, Fleisher et al. 1994) or other immunosuppressive drugs used to control the immune system. For example, Hydroyurea (HU) is a typical chemotherapy cytostatic treatment that non-specifically synchronizes all dividing cells and kills them. This drug particularly affects haematopoietic and lymphoid cells having high frequencies of cells in division and thus induces immunosuppressive effects. Experiments using HU allowed to reveal the reduced B cell functionality post-treatment in mice (Rusthoven and Phillips 1980). Such type of experiments and others like transfer experiment or labelling of dividing cells, were used to investigate population dynamics in the mouse and revealed the high turnover of B cells (Freitas, Rocha et al. 1982) reviewed in Freitas, Rocha et al. 1986). This high dynamic immune system display in fact internal activities observed in non-manipulated mice (Freitas, Pereira et al. 1989). We have also shown that the cellular environment determines the life-span of B cells by selection processes (Thomas-Vaslin and Freitas 1989). This drives clonal persistence of B cells through the variable region selection of the BCR (Thomas-Vaslin, Andrade et al. 1991), contributing to shape the B cell repertoire with aging (Andrade, Huetz et al. 1991). In T cells, similar HU immunosuppressive treatment revealed the short life expectancy, the continuous renewal and post thymic expansion of T cells (Rocha 1987). In fact, lymphocytes are under homeostatic control to regulate the growth and survival of T and B cells that occupy and compete for different "ecological niches" (Freitas and Rocha 2000). Several other methods have allowed to explore T cell dynamics by conditional ablation, using depleting antibodies (Qin, Wise et al. 1990;Waldmann and Cobbold 1998;Bourgeois and Stockinger 2006) chemical thymectomy (Bourgeois, Hao et al. 2008) or lymphocyte proliferation in immunocompromised recipients. This highly dynamical system makes it very sensible and reactive to antigen stimulations, but also to immunosuppressive treatments. Moreover immunostimulatory and rejuvenation treatments are explored to stimulate the immune system in aging or after immunosuppression (Dudakov, Goldberg et al. 2009;Lynch, Goldberg et al. 2009). Several factors like Keratinocyte growth factor, Growth hormone, cytokines like IL-7, IL-15 or IL2, steroid hormones are implicated in aging process. Immuno-stimulatory pathways and rejuvenation treatments are experimented to prevent or revert the immunodepression (Zuniga-Pflucker and van den Brink 2007; Dorshkind, Montecino-Rodriguez et al. 2009;Mackall, Fry et al. 2011). In particular, some hormones like Growth Hormone (GH) and Ghrelin stimulate thymic production, GH normalizing the T cell repertoire (Taub, Murphy et al. 2010).

Immunosuppression & aging: Some examples
Our comprehension of processes of immunodepression with aging or effect of immunosuppression requires the understanding of lymphocyte dynamics and the global description of lymphocyte populations. The Figure 1 depicts hypothetical T cell population subsets in the thymus and peripheral organs, with cell division, process of selection and death, differentiation from one population to another one. The investigation and modelling of cell population dynamics is often based on knowledge obtained from young individuals that can be considered at steady for a short time period in absence of intentional immunisation. Alterations of the system and observation of the responses to perturbations is also a way to understand the systems properties. As stated before, modelling cell population dynamics is an active field of research in systems immunology and a plenty of model of T cell dynamics have been proposed (Mehr, Globerson et al. 1995;Mehr, Perelson et al. 1997;Efroni, Harel et al. 2007;Asquith, Borghans et al. 2009;Dowling and Hodgkin 2009;Souza-e-Silva, Savino et al. 2009). Our mathematical model of T cell dynamics is based on a conveyor-belt model of differentiation (Thomas-Vaslin, Altes et al. 2008) as summarised below in Figure 4. Here, we (1) give some examples of the effects of aging on T cell population composition and repertoire, (2) show the additive effects of transient or chronic immunosuppression, (3) investigated the effects of rejuvenation treatments on T cells repertoire.

The physiological aging process & genetic influence
In order to quantify immunological alterations process through physiological aging we have studied the organ distribution, phenotype, repertoire and dynamics of T lymphocytes from young (2 months) to aged (25 months) mice. We have also evaluated the effect of genetic influences known to determine for example the CD4/CD8 ratio (Kraal, Weissman et al. 1983). Thus, two different mouse genetic backgrounds identified to provide various quality of repertoire selection and aging processes in non-manipulated lab mice C57BL/6 (B6) (H-2 b ) and FVB (H-2 q ) were used.

T cell populations and cell counts
Multicolour flow cytometry allows to define the phenotype of single cells and to identify thymocyte populations as CD4 lo CD8 lo (DN), CD4 hi CD8 hi (DP) and mature T cell CD4 and In young mice, the CD4 and CD8 percentages are characteristic of each lymphoid tissue as thymus, spleen, lymph nodes (Fig.2B). The variability between individuals is low, and a typical CD4/CD8 ratio is displayed according to genetic characteristics and organs (decreasing from 3.2 in thymus to 1.4 in lymph nodes in B6 mice, while from 5.0 to 2.1 in FVB). In old mice, this typical pattern is altered with high variability from mouse to mouse, increased proportion of either CD4 or CD8 T cells that correspond to clonal expansions of peripheral CD44 hi T cells. Thymic involution is accelerated in FVB mice compared to B6 (Fig.2C) with a 10 times decrease of thymocyte number between 2 months to 2 years. The acceleration of thymic involution in FVB might be related to alteration of thymic epithelial cell differentiation (Nabarra, Mulotte et al. 2001) that in turn could affect the early www.intechopen.com differentiation of thymocytes. After thymic differentiation and selection, T lymphocytes reach peripheral organs as naïve CD44 lo T cells, where they can encounter antigens. In the spleen, the number of naïve T cells decreases with aging due to decreased thymic production, while those of CD44 hi T cells increased due to recruitment by antigenic stimulation. With aging the T cell population production is thus perturbed with less naïve production compensated in part by effector and memory T cell accumulation. Note that FVB young mice have twice the numbers of CD4 naïve T cells compared to B6, while other population looks quite similar, suggesting different selection processes and T cell population dynamics. With aging, alterations are higher in FVB due to the massive loss of naïve CD4 T cells while there is higher accumulation of CD8 CD44 hi T cells. Thus, FVB mice display an accelerated "immunological aging" compared to B6 mice.

T cell repertoire diversity
The diversity and variability of the TCR lymphocyte repertoire in young or old mice is an important point that is critical for the ability of an individual to respond to a huge variety of www.intechopen.com antigen. The potential diversity of T lymphocyte in mouse is estimated to 10 15 while the size of splenic TCR repertoire is estimated to 2x10 6 with a clonal size of 30-40 cells in young mice (Casrouge, Beaudoing et al. 2000). Although initially random rearrangement processes favour TCR diversity selection process, selection of particular TCR with germline encoded CDR1 and CDR2 sequence interacting with MHC also allows to control thymic selection (Scott-Browne, White et al. 2009;Jenkins, Chu et al. 2010). In B6, while there are Mammary tumour virus (Mtv) integrations in the genome, the absence of MHC II I-E expression avoids the superantigen presentation and prevents the deletion of some Vβ. Thus, in B6 mice the repertoire is very diversified compared to other strains that delete some Vβ related to superantigen recognition. FVB has a TCRβ chromosomal deletion of Vβ8 and 6 others Vβ (Osman, Hannibal et al. 1999). The TCR repertoire can be assessed either by FACS in individual CD4 or CD8 T cells with antibodies specific for each particular Vβ. Alternatively, Immunoscope analysis (Collette and Six 2002;Boudinot, Marriotti-Ferrandiz et al. 2008) allows measuring the variable length www.intechopen.com of the CDR3 region from the TCR involved in antigen recognition, for each Vβ family and to estimate the diversity for each Vβ. In young mice, we observed a very low variability in the TCR Vβ splenocyte repertoire, as shown for FVB mice in Figure 3. A typical signature of young FVB mice can be observed by FACS or immunoscope. In contrast, variability is observed in old mice, with occurrence of CD8 CD44 hi clonal expansion. This is confirmed by measuring CDR3 length expression by Immunoscope, as observance of non-Gaussian peak distribution. Some Vβ clones also disappear in old mice. Thus, perturbations are important in old mice restricting the diversity of the repertoire, and consequently the possibility to respond to antigens. The T lymphocyte repertoire diversity shrinks due to clonal amplification and deletion as a consequence of the decrease of de novo thymic production and chronic antigenic stimulation by the environmental antigens (Kieper, Troy et al. 2005). The magnitude of these alterations depends on aging but also on genetic or epigenetic influences since in B6 mice the alterations seem less prominent (see Figure 8).

Immunosuppression: The effect of transient conditional depletion of dividing T cells on the immune system
The depletion of dividing T cells leads to immunosuppression. This could be the result of an immunotherapy to control the reactivity of the T cells involved in immune responses (allograft rejection, Graft versus host disease, autoimmunity, inflammatory diseases), or the consequences of anti-tumour chemotherapy targeting dividing tumour cells. Experimental T cell depletion can also be used to estimate the natural division, turnover of T cells and to evaluate the homeostatic capacity of the immune system to reconstitute. We previously studied the effects of transient conditional immunosuppression through the killing of dividing T cells by different methods.

Hydroxyurea
As reviewed above, Hydroxyurea a cytostatic agent targeting dividing cells, has allowed to investigate renewal rates and differentiation of T cells and B cells (Rocha, Freitas et al. 1983;Cumano, Vieira et al. 1986;. We have shown that HU treatment also induces "immune amnesia", i.e. this immunosuppressive treatments kills lymphocytes involved in the memory maintenance process and thus the treatment prevents secondary memory immune response (Bellier, Thomas-Vaslin et al. 2003). Moreover, we showed that the depletion of dividing cells induced by HU provokes an homeostatic perturbation that displace effector/regulatory T cells ratio, inducing dominant transplantation tolerance (Giraud, Barrou et al. 2008). Thus, depleting dividing cells is a way to manipulate the immune system and immune responses.

Pharmaco-genetic conditional immunosuppression
To restrict the effect of chemotherapy to lymphocytes, engineering a specific conditional pharmaco-genetic immunosuppression in mice expressing the HSV1-TK suicide (TK) gene has allowed to achieve the ablation of B and T cell lineages (Heyman, Borrelli et al. 1989). To achieve specific T cell depletion we engineered mice expressing the suicide gene (TK+) under a CD4 enhancer and promoter: upon a nucleoside analogue as ganciclovir (GCV) treatment in these TK + transgenic mice, only the CD4 and CD8 T cells that are in division are killed, while all other body cells can continue to divide.

Transient depletion of dividing T cells to evaluate T cells dynamics
Using the TK/GCV strategy, we have shown the effect of transient (1 week) dividing T cells depletion followed by an homeostatic recovery of the various T cell subsets in the thymus and spleen of young adult mice. The mathematical modelling of these experimental data, showing depletion and repletion of T cells compartment led us to evaluate the impact of dividing cell depletion treatment on T cells, the time necessary to return to pre-treatment values. Moreover, it allows to estimate parameters values at the steady state describing the continuous T cell differentiation, fluxes, cell division in the thymus and spleen of young adult mice (Thomas-Vaslin, Altes et al. 2008). Figure 4 depicts the results of this model in young FVB mice and estimation of T cell composition in old mice from our experimental data.  Thomas-Vaslin, Altes et al. 2008). In old mice, the thymus was involuted, thus the naïve T cell is considerably reduced while the population of Ag-experiment T cells had increased following chronic antigenic challenges.

Transient depletion of dividing T cells induces the lack of immunological memory maintenance
We have also studied the effects of a time controlled specific T cell depletion in immune mice, using the TK/GCV pharmacogenetic control and shown the lack of secondary immune response following such a treatment, confirming the effects observed with HU treatment (Bellier, Thomas-Vaslin et al. 2003). Fig. 5. Effect of immunosuppression on the immunological memory maintenance: B6 female mice were sensitized on day 0 to male skin antigen through a male skin graft. Female mice rejected this first male graft in about 30 days with a typical primary rejection kinetics (yellow symbols). After establishment of immune memory, the dividing T cells were depleted for 2 to 5 weeks. After cessation of treatment a second skin graft is performed and the kinetics of rejection is observed: in mice where the depletion of dividing T cells is inefficient (TK-GCV+) all skin grafts are rapidly rejected in less than 20 days, with a typical acceleration compatible with a second set kinetics (blue symbols). In mice where the depletion of dividing cells is efficient (TK+GCV+, orange symbols) the grafts are rejected with a primary set kinetics. Figure 5 depicts an example of T cell immune memory failure in the case of sensitisation with an allogeneic skin graft. Similar lack of memory responses were observed after the viral infection of mice with the lymphocytic choriomeningitis virus (LCMV). This demonstrates that immunological memory is maintained by a pool of T cells in constant division, which is sensible to some immunosuppressive treatments. This effect could be a drawback of immunosuppressant that might disturb the beneficial immune memory induced by vaccination. However, it also suggests that such immunosuppressive treatment could be used to target dividing cells responsible of undesirable memory T cell response (as in allograft sensitized recipient).

Specific transient depletion of dividing T cells to control immunopathological T cell responses
Used in pathological situations, the conditional pharmacogenetic immunosuppression induced by the TK/GCV system allows to (i) transiently control LCMV infection (Boyer, Cohen et al. 2000). (ii) control GVHD (Cohen, Boyer et al. 1997;Cohen, Saron et al. 2000;Cohen, Boyer et al. 2001). Clinical protocol associated with injection of regulatory T cells expressing the TK gene as a safety gene to control GVHD are under assessment (Guillot-Delost, Cherai et al. 2008). Applied upon an allograft this treatment allows delayed rejection (skin graft) or tolerance of the graft (vascularized heart allograft) (Braunberger, Cohen et al. 2000;Braunberger, Raynal-Raschilas et al. 2000;Thomas-Vaslin, Bellier et al. 2000). In fact, we further showed that the depletion treatment (either HU or TK/GCV) induces disequilibrium favouring regulatory T cells (Treg) responsible for dominant tolerance able to control islet pancreatic allografts rejection (Giraud, Barrou et al. 2008). While aging by itself leads to multilevel alterations and finally immunodepression at biological level, little is know about the additive effect of clinical immunosuppression during aging. Observations that allograft rejection is decreased in old recipient lead to recommendations that older recipient may require less immunosuppression than young patients to control allograft rejection and to treat autoimmunity or inflammation diseases (Bradley 2002).

Effect of transient depletion of dividing T cells according to age
We have compared the kinetics of T cells in mice during and after a transient depletion of dividing T cells according to the age of the mice. In young adult mice, the immunosuppressive treatment applied during two weeks initially induces the depletion of naïve T (CD44 lo ) cells in FVB mice and in both naïve and effector/memory (CD44 hi ) T cell in B6 mice ( Figure 6). Then, homeostatic recovery occurs within two months and both strains recovered initial T lymphocyte counts. In contrast, in aged mice the two weeks ganciclovir treatment induces in FVB a continuous decrease of naïve T cells counts while effector/memory T cells accumulate. In B6 mice the GCV treatment induces less perturbation probably because the thymic involution is less prominent than in FVB at the same age. Thus reconstitution of naïve T cells can occur post treatment, while accumulation of effector/memory T cells is limited. The use of conditional pharmacogenetic immunosuppression has allowed proposing the model depicted in Figure 4 from mathematical modelling. Visual computer modelling of T cell population dynamics is currently under progress  to develop our comprehension of cell fluxes between cell compartment and organs, cell division. This modelling should allow quantifying parameter values in young to aged mice at steady state, but also simulating some treatments, to confirm our experimental observations and hypothesis. www.intechopen.com

www.intechopen.com
The analysis of the TCR Vß repertoire following the pharmacogenetic immunosuppression (Figure 7) revealed major alterations in the CD8 T cells from aged FVB mice with either oligoclonal expansion (representing up to 60 millions of cells) or partial clonal deletion (manuscript in preparation). In contrast, in B6 mice the alterations following treatment are more limited although detectable. Again the slower "immunological aging" of B6 mice seems to preserve homeostatic recovery and the T cell repertoire diversity.

Prevention of aging and immunodepression
IL-2 has been shown to have a dual role in CD8 memory maintenance, being able to inhibit the proliferation of CD8 memory T cells (Dai, Konieczny et al. 2000) via down regulation of the γc chain expression of its receptor, increasing apoptotic cell death (Li, Demirci et al. 2001). The growth of very large CD8 T cell clones observed in old mice was attributed to cytokine deregulation, IL-15 being stimulatory, while IL-2 is inhibitory (Ku, Kappler et al. 2001). IL-2 is a cytokine that acts centrally and peripherally to increase CD4 naïve T cell numbers (Foussat, Bouchet-Delbos et al. 2004). There is a defect of IL-2 production by CD4 T cells from aged mice, reducing their expansion capacity (Haynes, Linton et al. 1999). IL-2 is also necessary to maintain CD4 + CD25 + regulatory T cells that control CD4 T cell homeostasis (Almeida, Legrand et al. 2002). CD4 + CD25 + regulatory T cells are involved in IL-2 mediated inhibition of memory CD8 T cells, reducing their division (Murakami, Sakamoto et al. 2002). Regulatory T cells were shown to accumulate with aging contributing to decrease immune responses. However the augmentation of suppressive function is not due to CD4 + CD25 + Foxp3 + T cells but to CD4 + CD25 -Foxp3+ T cells that appear with aging (Nishioka, Shimizu et al. 2006). Since a lack of IL-2 secretion is reported in old individuals, with deficiency in CD4 help, IL-2 treatments were assessed and shown to increase Treg cell numbers in lymphopenic individuals (Zhang, Chua et al. 2005). The role of Treg in the prevention of repertoire alteration was also shown in the case of lymphopenia induced proliferation (Winstead, Reilly et al.). Treg also modulate the effector function of CD8 by competing for IL-2 (McNally, Hill et al. 2011). IL-2 also has positive effect to control T cell homeostasis in autoimmunity (Humrich, Morbach et al.). In NOD type-1 diabetic mice, IL-2 can prevent or reverse autoimmunity, by stimulation of Tregs (Grinberg-Bleyer, Baeyens et al.). In infectious diseases, HIV infected patient IL-2 treatment induces an increase of thymic export (Carcelain, Saint-Mezard et al. 2003) and induces a peripheral CD4 T cell expansion by limiting CD4 proliferation and increasing CD4CD25+ subset (Sereti, Anthony et al. 2004). To prevent the effects of aging homeostatic deregulation and TCR repertoire alterations, we tested the effect of IL-2 or transfer of regulatory T cells (CD4+CD25+) injected in middleaged B6 mice (15-month old) (Figure 8). Both treatments prevent clonal alterations as revealed by FACS analysis of TCRVB repertoire at the age of 24-28 months. Non-treated B6 mice developed by 24-28 months oligoclonal expansions essentially in CD4 T cells and loose CD8 T cell clones. IL-2 treated mice have lower CD4 clonal expansions, that are absent in Treg treated mice and repertoire looks "younger". Both treatments limited the decrease of CD8 cell clones. Note that at variance with FVB mice, in B6 mice the aging of the repertoire is delayed, and that oligoclonal expansions concern mostly CD4 T cells in B6 but CD8 T cells in FVB.
www.intechopen.com Fig. 8. Vß TCR repertoire by FACS of spleen cells from B6 mice, showing the number of each Vß in CD4 vs. CD8 T cells, in non treated B6 mice according to age, and in B6 mice that received an IL-2 treatment or an injection of regulatory T cells (CD25+) at the age of 15 months and are analysed at the age of 24-28 months.

Conclusions
We pointed out that the different initial T cell numbers available according to age and genetic background determines the kinetics of depletion and recovery in B6 and FVB mice. This suggests that the T cell dynamics and turnover differs according to genetic influence. FVB mice have an accelerated immunological aging, with accelerated thymic involution and finally accumulation of CD8 clonal T cell expansions by 22 months. The transient depletion of dividing T cells temporarily disturb the dynamic T cell equilibrium of young mice of both genetic background, with a return to steady-state values and no alteration in repertoire diversity. However, in middle-aged mice the effect of the transient depletion can be more dramatic: in FVB mice it leads to accelerated occurrence of CD8 T cell clones. In B6 mice, the www.intechopen.com long term consequences of treatment are less important, most likely because the thymus is more productive at the same age. However, we also observed that a preventive treatment by serial injection of IL-2 or a single injection of Treg cells in middle aged mice can successfully prevent the natural occurrence of repertoire alterations. Our work allows us to observe the physiological aging that impacts on the quality and quantity of T cells in the central and peripheral organs as well as on the diversity of the repertoire. It indicates that some immunosuppressive treatments inducing a homeostatic disturbance of the immune systems might accelerate the aging of the T cell composition and reduce the TCR repertoire diversity, while some immunostimulatory treatment or regulatory T cells might prevent such alterations. As underlined before, several biological scales are involved in these processes and the variability observed between genetic background, ages of the same individual at the level of cell population, cells or TCR cellular or molecular repertoire have to be evaluated. Use of systems immunology approaches as multidimensional statistical models (Pham, in preparation) and computer models (McEwan, in preparation) are novel approaches that will give a more thorough evaluation of complex T cell population dynamics to be able to simulate the physiological behaviour and effects of perturbations. A need for a book on immunology which primarily focuses on the needs of medical and clinical research students was recognized. This book, "Immunosuppression -Role in Health and Diseases" is relatively short and contains topics relevant to the understanding of human immune system and its role in health and diseases. Immunosuppression involves an act that reduces the activation or efficacy of the immune system. Therapeutic immunosuppression has applications in clinical medicine, ranging from prevention and treatment of organ/bone marrow transplant rejection, management of autoimmune and inflammatory disorders. It brings important developments both in the field of molecular mechanisms involved and active therapeutic approaches employed for immunosuppression in various human disease conditions. There was a need to bring this information together in a single volume, as much of the recent developments are dispersed throughout biomedical literature, largely in specialized journals. This book will serve well the practicing physicians, surgeons and biomedical scientists as it provides an insight into various approaches to immunosuppression and reviews current developments in each area.